Phage Therapy: A Targeted Solution for Brucellosis

Area of Science:

• Microbiology
• Infectious Diseases
• Zoonotic Infections

Background:

• Brucellosis is a significant zoonotic bacterial infection impacting over 500,000 individuals annually.
• High relapse rates (10-15%) persist despite conventional antibiotic treatments.
• Economic losses in livestock are substantial, particularly in endemic regions.

Purpose of the Study:

• To review the current understanding of brucellosis and its impact on animal and human health.
• To explore bacteriophage therapy as a potential alternative for brucellosis management.
• To discuss emerging therapies including immunotherapy and novel vaccines.

Main Methods:

• Literature review on brucellosis epidemiology and pathogenesis.
• Analysis of bacteriophage mechanisms and efficacy against Brucella species.
• Exploration of strategies to enhance phage therapy effectiveness.

Main Results:

• Bacteriophages demonstrate selective targeting and lysis of Brucella spp.
• Phage specificity, immune modulation, and advanced encapsulation techniques are key to enhancing efficacy.
• Current research indicates phage therapy's potential as a viable alternative.

Conclusions:

• Phage therapy presents a promising alternative to conventional antibiotics for brucellosis.
• Immunotherapy and novel vaccine strategies are also being explored to reduce disease burden.
• Further research into these alternative therapies is crucial for improved clinical outcomes.